Literature DB >> 33377636

Identification of a novel 15-gene expression signature predicting overall survival of human colorectal cancer.

Chengfei Jiang1, Yue Zhao2, Binbin Yuan1, Hang Chang3, Bo Hang3, Antoine M Snijders3, Jian-Hua Mao3, Xiaoping Zou1, Pin Wang1.   

Abstract

Entities:  

Year:  2020        PMID： 33377636      PMCID： PMC7759535          DOI： 10.1002/ctm2.258

Source DB:  PubMed          Journal:  Clin Transl Med        ISSN： 2001-1326


× No keyword cloud information.
  10 in total

1.  Evaluation of DNA microarray results with quantitative gene expression platforms.

Authors:  Roger D Canales; Yuling Luo; James C Willey; Bradley Austermiller; Catalin C Barbacioru; Cecilie Boysen; Kathryn Hunkapiller; Roderick V Jensen; Charles R Knight; Kathleen Y Lee; Yunqing Ma; Botoul Maqsodi; Adam Papallo; Elizabeth Herness Peters; Karen Poulter; Patricia L Ruppel; Raymond R Samaha; Leming Shi; Wen Yang; Lu Zhang; Federico M Goodsaid
Journal:  Nat Biotechnol       Date:  2006-09       Impact factor: 54.908

2.  Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas.

Authors:  Yang Liu; Nilay S Sethi; Toshinori Hinoue; Barbara G Schneider; Andrew D Cherniack; Francisco Sanchez-Vega; Jose A Seoane; Farshad Farshidfar; Reanne Bowlby; Mirazul Islam; Jaegil Kim; Walid Chatila; Rehan Akbani; Rupa S Kanchi; Charles S Rabkin; Joseph E Willis; Kenneth K Wang; Shannon J McCall; Lopa Mishra; Akinyemi I Ojesina; Susan Bullman; Chandra Sekhar Pedamallu; Alexander J Lazar; Ryo Sakai; Vésteinn Thorsson; Adam J Bass; Peter W Laird
Journal:  Cancer Cell       Date:  2018-04-02       Impact factor: 31.743

3.  Prospective multicenter study of the impact of oncotype DX colon cancer assay results on treatment recommendations in stage II colon cancer patients.

Authors:  Geetika Srivastava; Lindsay A Renfro; Robert J Behrens; Margarita Lopatin; Calvin Chao; Gamini S Soori; Shaker R Dakhil; Rex B Mowat; J Philip Kuebler; George Kim; Miroslaw Mazurczak; Mark Lee; Steven R Alberts
Journal:  Oncologist       Date:  2014-04-07

4.  Impact of the 12-Gene Colon Cancer Assay on Clinical Decision Making for Adjuvant Therapy in Stage II Colon Cancer Patients.

Authors:  Baruch Brenner; Ravit Geva; Megan Rothney; Alexander Beny; Ygael Dror; Mariana Steiner; Ayala Hubert; Efraim Idelevich; Alexander Gluzman; Ofer Purim; Einat Shacham-Shmueli; Katerina Shulman; Moshe Mishaeli; Sophia Man; Lior Soussan-Gutman; Haluk Tezcan; Calvin Chao; Adi Shani; Nicky Liebermann
Journal:  Value Health       Date:  2015-10-30       Impact factor: 5.725

5.  Translating tumor biology into personalized treatment planning: analytical performance characteristics of the Oncotype DX Colon Cancer Assay.

Authors:  Kim M Clark-Langone; Chithra Sangli; Jayadevi Krishnakumar; Drew Watson
Journal:  BMC Cancer       Date:  2010-12-23       Impact factor: 4.430

6.  A novel gene expression-based prognostic scoring system to predict survival in gastric cancer.

Authors:  Pin Wang; Yunshan Wang; Bo Hang; Xiaoping Zou; Jian-Hua Mao
Journal:  Oncotarget       Date:  2016-08-23

7.  A robust gene expression-based prognostic risk score predicts overall survival of lung adenocarcinoma patients.

Authors:  En-Guo Chen; Pin Wang; Haizhou Lou; Yunshan Wang; Hong Yan; Lei Bi; Liang Liu; Bin Li; Antoine M Snijders; Jian-Hua Mao; Bo Hang
Journal:  Oncotarget       Date:  2017-12-15

8.  The global, regional, and national burden of colorectal cancer and its attributable risk factors in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.

Authors: 
Journal:  Lancet Gastroenterol Hepatol       Date:  2019-10-21

9.  Clinically applicable 53-Gene prognostic assay predicts chemotherapy benefit in gastric cancer: A multicenter study.

Authors:  Linghua Zhu; Haifeng Wang; Chengfei Jiang; Wenhuan Li; Shuting Zhai; Xiujun Cai; Xianfa Wang; Linghong Liao; Feng Tao; Dexi Jin; Guofu Chen; Yankai Xia; Jian-Hua Mao; Bin Li; Pin Wang; Bo Hang
Journal:  EBioMedicine       Date:  2020-10-14       Impact factor: 8.143

10.  A Robust Gene Expression Prognostic Signature for Overall Survival in High-Grade Serous Ovarian Cancer.

Authors:  Yue Zhao; Shao-Min Yang; Yu-Lan Jin; Guang-Wu Xiong; Pin Wang; Antoine M Snijders; Jian-Hua Mao; Xiao-Wei Zhang; Bo Hang
Journal:  J Oncol       Date:  2019-11-07       Impact factor: 4.375
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.